• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

按地理区域和种族划分的年龄相关性黄斑病变患病率。

The prevalence of age-related maculopathy by geographic region and ethnicity.

作者信息

Klein R, Klein B E, Cruickshanks K J

机构信息

Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, 53705-2397, USA.

出版信息

Prog Retin Eye Res. 1999 May;18(3):371-89. doi: 10.1016/s1350-9462(98)00025-1.

DOI:10.1016/s1350-9462(98)00025-1
PMID:10192518
Abstract

The prevalence of age-related maculopathy (ARM) varies considerably in different locations and racial/ethnic groups around the world. At present there are insufficient data to determine whether it is likely that these differences in prevalence, especially for the early forms of ARM are due to variations in genetic and environmental factors or due to variations in age of the cohorts and methods used to ascertain and define ARM. In three population-based studies of whites living in Beaver Dam, Wisconsin, Blue Mountains, Australia, and Rotterdam, The Netherlands, in which similar methods of ascertainment and classification were used to detect and define ARM, late ARM was present in 1.2%, 1.4%, and 1.2% of the population less than 86 years of age, respectively. While data from clinical studies suggest that late ARM associated with choroidal neovascularization is rare in blacks compared with whites, some epidemiological studies suggest that late ARM may be similar in blacks and whites. There are still too few data from various ethnic/racial groups around the world and too few population-based data in older Hispanic and Asian populations to make meaningful comparisons. There is a need for further research into the distribution of ARM and its possible causes using similar methodologies to ascertain and define the disease. Further insights will be gained when genotypes associated with ARM are discovered.

摘要

年龄相关性黄斑病变(ARM)的患病率在世界各地不同地区以及不同种族/民族群体中差异很大。目前,尚无足够数据来确定这些患病率差异,尤其是早期ARM的患病率差异,是由于遗传和环境因素的变化,还是由于队列人群年龄以及用于确定和定义ARM的方法的差异所致。在三项针对居住在威斯康星州比弗迪尔、澳大利亚蓝山以及荷兰鹿特丹的白人的基于人群的研究中,采用了相似的确定和分类方法来检测和定义ARM,86岁以下人群中晚期ARM的患病率分别为1.2%、1.4%和1.2%。虽然临床研究数据表明,与白人相比,黑人中与脉络膜新生血管相关的晚期ARM较为罕见,但一些流行病学研究表明,黑人和白人中的晚期ARM可能相似。目前,来自世界各地不同种族/民族群体的数据仍然太少,针对老年西班牙裔和亚洲人群的基于人群的数据也太少,无法进行有意义的比较。有必要采用相似的方法来确定和定义该疾病,进一步研究ARM的分布及其可能的病因。当发现与ARM相关的基因型时,将会获得更多见解。

相似文献

1
The prevalence of age-related maculopathy by geographic region and ethnicity.按地理区域和种族划分的年龄相关性黄斑病变患病率。
Prog Retin Eye Res. 1999 May;18(3):371-89. doi: 10.1016/s1350-9462(98)00025-1.
2
The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy.按地理区域和种族划分的年龄相关性黄斑病变患病率。科罗拉多-威斯康星年龄相关性黄斑病变研究。
Arch Ophthalmol. 1997 Feb;115(2):242-50. doi: 10.1001/archopht.1997.01100150244015.
3
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.全球与年龄相关的黄斑变性患病率及 2020 与 2040 年疾病负担预测:系统回顾和荟萃分析。
Lancet Glob Health. 2014 Feb;2(2):e106-16. doi: 10.1016/S2214-109X(13)70145-1. Epub 2014 Jan 3.
4
Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies.白内障手术与晚期年龄相关性黄斑病变的5年发病率:比弗迪姆和蓝山眼研究的汇总结果
Ophthalmology. 2003 Oct;110(10):1960-7. doi: 10.1016/s0161-6420(03)00816-9.
5
Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study.年龄相关性黄斑病变的五年发病率:蓝山眼研究
Ophthalmology. 2002 Jun;109(6):1092-7. doi: 10.1016/s0161-6420(02)01055-2.
6
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.澳大利亚年龄相关性黄斑病变的患病率。蓝山眼研究。
Ophthalmology. 1995 Oct;102(10):1450-60. doi: 10.1016/s0161-6420(95)30846-9.
7
Age related maculopathy and diabetes.年龄相关性黄斑病变与糖尿病。
Eur J Ophthalmol. 2008 Nov-Dec;18(6):949-54. doi: 10.1177/112067210801800615.
8
Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.年龄相关性黄斑病变的十年发病率及病情进展:蓝山眼研究
Ophthalmology. 2007 Jan;114(1):92-8. doi: 10.1016/j.ophtha.2006.07.017.
9
Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study.社区动脉粥样硬化风险研究中年龄相关性黄斑病变的患病率。
Arch Ophthalmol. 1999 Sep;117(9):1203-10. doi: 10.1001/archopht.117.9.1203.
10
Risk factors for age-related macular degeneration: Pooled findings from three continents.年龄相关性黄斑变性的风险因素:来自三大洲的汇总研究结果。
Ophthalmology. 2001 Apr;108(4):697-704. doi: 10.1016/s0161-6420(00)00580-7.

引用本文的文献

1
Towards Motion Compensation in Autonomous Robotic Subretinal Injections.迈向自主机器人视网膜下注射中的运动补偿
Int Symp Med Robot. 2025 May;2025:66-72. doi: 10.1109/ismr67322.2025.11025990. Epub 2025 Jun 13.
2
Advances in Electrode Design and Physiological Considerations for Retinal Implants.视网膜植入物的电极设计进展及生理考量
Micromachines (Basel). 2025 May 21;16(5):598. doi: 10.3390/mi16050598.
3
Sema4D Knockout Attenuates Choroidal Neovascularization by Inhibiting M2 Macrophage Polarization Via Regulation of the RhoA/ROCK Pathway.
Sema4D 敲除通过调节 RhoA/ROCK 通路抑制 M2 巨噬细胞极化来减轻脉络膜新生血管。
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):34. doi: 10.1167/iovs.65.6.34.
4
Pseudoxanthoma elasticum - Genetics, pathophysiology, and clinical presentation.弹性假黄瘤-遗传学、病理生理学和临床表现。
Prog Retin Eye Res. 2024 Sep;102:101274. doi: 10.1016/j.preteyeres.2024.101274. Epub 2024 May 28.
5
Technological Perception with Rural and Urban Differentiation and Its Influence on the Quality of Life of Older People with Age-Related Macular Degeneration.城乡差异下的技术认知及其对老年黄斑变性患者生活质量的影响
Eur J Investig Health Psychol Educ. 2024 May 20;14(5):1470-1488. doi: 10.3390/ejihpe14050097.
6
Efficacy and safety of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review and meta-analysis.玻璃体内 faricimab 治疗新生血管性年龄相关性黄斑变性的疗效和安全性:系统评价和荟萃分析。
Sci Rep. 2024 Jan 30;14(1):2485. doi: 10.1038/s41598-024-52942-3.
7
Accelerated Brain Atrophy, Microstructural Decline and Connectopathy in Age-Related Macular Degeneration.年龄相关性黄斑变性中的脑萎缩加速、微观结构衰退和连接病
Biomedicines. 2024 Jan 10;12(1):147. doi: 10.3390/biomedicines12010147.
8
Targeting cell-type-specific, choroid-peripheral immune signaling to treat age-related macular degeneration.针对眼周脉络膜免疫信号的细胞类型特异性治疗方法,用于治疗年龄相关性黄斑变性。
Cell Rep Med. 2024 Jan 16;5(1):101353. doi: 10.1016/j.xcrm.2023.101353.
9
AMD and Stem Cell-Based Therapies.AMD 与基于干细胞的疗法。
Int Ophthalmol Clin. 2024 Jan 1;64(1):21-33. doi: 10.1097/IIO.0000000000000510. Epub 2023 Dec 26.
10
Recent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review.新生血管性年龄相关性黄斑变性基因治疗的最新进展:综述
Biomedicines. 2023 Dec 5;11(12):3221. doi: 10.3390/biomedicines11123221.